Please check your internet connection and try again.
# Lorazepam (Benzodiazepine)
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, anticonvulsant, and muscle relaxant properties.
## Primary Indications
* Anxiety disorders
* Insomnia (short-term treatment)
* Status epilepticus (acute treatment)
* Premedication for medical/surgical procedures
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally 2-3 times daily. Maximum: 10 mg/day.
* **Insomnia:** 2 mg to 4 mg orally at bedtime. Typically for short-term use only.
* **Status Epilepticus:** 4 mg IV/IM. May be repeated after 5-10 minutes if seizures persist. Maximum: 8 mg in a 12-hour period.
* **Premedication:** 2 mg to 4 mg IM 2 hours before surgery, or 2 mg to 4 mg IV 30 minutes before induction of anesthesia.
## Pediatric Dosing
Dosing in pediatric patients can vary significantly and is often based on weight and clinical indication. Consult specific pediatric guidelines or protocols.
* **Status Epilepticus:**
* 1 month to 5 years: 0.05 mg/kg IV/IM, not to exceed 2 mg per dose. May repeat once after 10-15 minutes.
* 5 years to 12 years: 0.05 mg/kg IV/IM, not to exceed 4 mg per dose. May repeat once after 10-15 minutes.
* **Anxiety/Sedation:** Dosing is highly individualized and often lower than adult doses. Consult specific pediatric protocols.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; may require dose reduction.
* **Renal Impairment:** No specific dose adjustment, but monitor for accumulation.
* **Elderly:** Start with lower doses (e.g., 0.5 mg twice daily) and titrate cautiously due to increased sensitivity and risk of adverse effects.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency.
* Sleep apnea.
## Adverse Effects
* **Common:** Sedation, drowsiness, dizziness, weakness, ataxia.
* **Less Common:** Confusion, depression, anterograde amnesia, paradoxical excitement, respiratory depression (especially with IV administration or in combination with other CNS depressants).
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, sedating antihistamines, other benzodiazepines, barbiturates):** Additive CNS depression, increased risk of sedation, respiratory depression, and death. Use with extreme caution or avoid.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic acid:** May increase plasma concentrations of lorazepam.
## Monitoring
* Level of consciousness and sedation.
* Respiratory rate and oxygen saturation (especially with IV administration).
* Signs of withdrawal upon discontinuation (e.g., anxiety, insomnia, tremors, nausea).
* Cognitive function.
## Clinical Pearls
* Lorazepam has a relatively intermediate half-life compared to other benzodiazepines.
* IV lorazepam can cause hypotension and respiratory depression. Administer slowly and monitor vital signs.
* Avoid abrupt discontinuation; taper dose gradually to minimize withdrawal symptoms.
* Due to its potential for abuse and dependence, use for the shortest duration necessary.
* Use is generally not recommended for primary treatment of chronic insomnia or depression.
***
**Disclaimer:** This information is intended for clinical use and does not replace professional medical advice. Always consult the most current prescribing information and institutional protocols before making any treatment decisions.
